| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMPHOTERICIN B | 062728 | 001 | ANDA | AMPHOTERICIN B | INJECTABLE;INJECTION | 50MG/VIAL | No | No | 1987/04/13 | 1987/04/13 | ABRAXIS PHARM | Discontinued |
| AMPHOTERICIN B | 063206 | 001 | ANDA | AMPHOTERICIN B | INJECTABLE;INJECTION | 50MG/VIAL | No | Yes | 1992/04/29 | 1992/04/29 | XGEN PHARMS | Prescription |
| AMPHOTERICIN B | 064062 | 001 | ANDA | AMPHOTERICIN B | INJECTABLE;INJECTION | 50MG/VIAL | No | No | 1995/03/31 | 1995/03/31 | TEVA PARENTERAL | Discontinued |
| AMPHOTERICIN B | 064141 | 001 | ANDA | AMPHOTERICIN B | INJECTABLE;INJECTION | 50MG/VIAL | No | No | 1996/12/23 | 1996/12/23 | ABBOTT | Discontinued |
| AMPHOTERICIN B | 212514 | 001 | ANDA | AMPHOTERICIN B | INJECTABLE, LIPOSOMAL;INJECTION | 50MG/VIAL | No | No | 2021/12/14 | 2021/12/14 | SPIL | Prescription |
| AMPHOTERICIN B | 214010 | 001 | ANDA | AMPHOTERICIN B | INJECTABLE, LIPOSOMAL;INJECTION | 50MG/VIAL | No | No | 2022/11/17 | 2022/11/17 | EUGIA PHARMA | Prescription |